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Severe Aortic Stenosis and Myocardial Function
Diagnostic and Prognostic Usefulness of Ultrasonic Integrated
Backscatter Analysis
Vitantonio Di Bello, MD; Davide Giorgi, MD; Paolo Viacava, MD; Talini Enrica, MD;
Carmela Nardi, MD; Caterina Palagi, MD; Maria Grazia Delle Donne, MD; Francesco Verunelli, MD;
Massimo A. Mariani, MD; Jean Grandjean, MD; Rita Dell’Anna, MD; Andrea Di Cori, MD;
Giulio Zucchelli, MD; Maria Francesca Romano, MD; Mario Mariani, MD
Background—The aim of this study was to assess the myocardial reflectivity pattern in severe aortic valve stenosis through the use
of integrated backscatter (IBS) analysis. Patients with aortic stenosis (AS) were carefully selected in the Department of Cardiology.
Methods and Results—Thirty-five subjects (AS: valve orifice 1 cm2; 12 female; mean age, 71.86.2 years) and 25 healthy
subjects were studied. All subjects of the study had conventional 2D-Doppler echocardiography and IBS. Backscatter signal
was sampled at the septum and posterior wall levels. Patients with AS were divided into 2 groups: 16 patients with initial signs
of congestive heart failure and a depressed left ventricular systolic function (DSF) (ejection fraction [EF] range, 35% to 50%)
and 19 asymptomatic patients with normal left ventricular systolic function (NSF) (EF 50%). Myocardial echo intensity
(pericardium related) was significantly higher at the septum and posterior wall levels in DSF than in NSF and in control
subjects. IBS variation, as an expression of variation of the signal, appeared to be significantly lower in AS with DSF than
in NSF and in control subjects, at both the septum and posterior wall levels. Patients with DSF underwent aortic valve
replacement, and, during surgical intervention, a septal myocardial biopsy was made for evaluation of myocardium/fibrosis
ratio. Abnormally increased echo intensity was detected in left ventricular pressure overload by severe aortic stenosis and
correlated with increase of myocardial collagen content (operating biopsy).
Conclusions—One year after aortic valve replacement, we observed a significant reduction of left ventricular mass, and,
only if pericardial indexed IBS value (reduction of interstitial fibrosis) decreased, it was possible to observe an
improvement of EF and of IBS variation. (Circulation. 2004;110:849-855.)
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Fibrosis is an early morphological alteration in patientswith aortic stenosis (AS); it is a major determinant of
diastolic dysfunction and systolic pumping capacity, and it is
one of the structural substrates for arrhythmogenicity, thus
playing a major role for sudden death and the progression of
congestive heart failure (CHF).1 Cell loss, mainly by autoph-
agy and oncosis, significantly contributes to the progression
of left ventricular (LV) systolic dysfunction.2 Hemodynamic
severity of AS is another important element, which, together
with clinical findings, is fundamental in decision-making
about patients.3 Once patients with AS become symptomatic
with angina, syncope, or CHF, average survival significantly
decreases, and for those patients, operative risk increases and
mortality rates are higher.4 Current hemodynamic assessment
of AS severity relies on indexes such as transvalvular
pressure gradient (P) and aortic valve area (AVA), obtained
by Doppler echocardiography. These indexes are suboptimal
because they correlate poorly with patient symptoms, provide
little prognostic information, and depend on flow rate; fur-
thermore, the appropriate cutoff values of P and AVA for
establishing disease severity are unclear.5
Quantitatively assessed ultrasonic backscatter signal (IBS) is
directly related to morphometrically evaluated collagen content
in human beings. Analysis of its dynamic aspects (cycle-
dependent variation of IBS) is useful to obtain information about
myocardial intrinsic contractile performance, independent of
wall motion.6,7 Furthermore, myocardial reflectivity (IBS) in
humans is directly related to myocardium collagen content.8
The aim of the study was to assess diagnostic and prog-
nostic values of integrated backscatter indexes in patients
with severe AS and in particular to test if these textural
indexes could have a real incremental value in comparison to
conventional echocardiographic systolic and diastolic func-
tional indexes in decision-making of this valvular pathology.
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Methods
Study Population
Two groups of strictly age-matched subjects were studied (case-
control study): 35 patients with AS, selected in the Department of
Cardiology (AS: valve orifice 1 cm2; 12 female; mean age,
71.86.2 years) and 25 healthy subjects of comparable age
(70.55.5 years), sex (9 female), and body mass index (AS:
25.12.7 versus control: 23.63.8; NS). Apart from no previous
myocardial infarction and a negative history of renal and connec-
tive tissue disease, selection criteria included absence of malig-
nant or accelerated hypertension, severe CHF, cardiomyopathy,
obesity, and diabetes. Once selected, all the participants under-
went echocardiography, thus reserving eligibility for coronary
angiography and cardiac catheterization; none had coronary
artery disease. Hemodynamic aortic valve area (AVAc), accord-
ing to the Gorlin equation, and peak-to-peak gradient were
calculated. Patients with AS were divided into 2 groups: 16
patients with initial signs of CHF and a depressed LV systolic
function (DSF) (ejection fraction [EF] range, 35% to 50%) (all in
New York Heart Association [NYHA] class II) and 19 who were
asymptomatic and with a normal LV systolic function (NSF) (EF
50%) (all in NYHA class I).
The 16 patients with symptomatic AS underwent aortic valve
replacement (10 with biological prosthesis and 6 with mechanic
prosthesis), and during surgical intervention, 10 underwent myocar-
dial biopsy at the proximal anterior interventricular septum level (left
side). Furthermore, they all were examined after 1 year for evalua-
tion of LV function by conventional echocardiographic and by
backscatter analysis (operating with the same system settings of the
echocardiograph in comparison with the previous study). The study
was approved by local ethical committee.
Experimental Procedures:
Doppler Echocardiography
Both systolic blood pressure (SBP) and diastolic blood pressure
(DBP) (Korotkoff phase V) were measured at the time of
echocardiographic examination by mercury sphygmomanometer
with patients in the supine position. The reported value was the
mean of several indirect recordings taken over a 30-minute
period. Body surface was calculated according to standard
formulas.
Conventional Doppler echocardiographic studies were performed
with a digital Philips Sonos 5500 echocardiograph with S3 probe.
Apart from conventional echocardiographic parameters previously
described,9 AVA and relative P were calculated by using continuity
and Bernoulli equations, respectively. Aortic regurgitation was
graded on the basis of color Doppler flow imaging (patients with
medium or severe aortic insufficiency were excluded). Valve aortic
resistance was calculated as 28 · P/AVA(AVR).10 Left ventric-
ular stroke work loss was expressed as a percentage and obtained as
100 · P/(PSBP).11
Acoustic Densitometry
Integrated backscatter imaging technology has been commercially
applied to provide a robust signal (calibrated in decibels) for
purposes of tissue characterization research. Acoustic densitometry
measurement is independent from nonlinear compression and post-
processing functions of the ultrasound imaging chain. The images
were obtained through the use of harmonic imaging mode, which is
able to determine an improvement of 2D image quality.12 A detailed
IBS methodology was used, as previously described.9
Other important control settings of the imaging chain such as
preprocessing, focus position, persistence, compression, frame rate,
and postprocessing were maintained constant for all patients, accu-
rately avoiding the signal saturation (ie, backscatter value sampled at
maximum value for the dynamic range of the system) at every level
(pericardium, valve, myocardium) for the possibility of estimation
errors. End-diastolic IBS parameters (IBSed) were then indexed for
IBS pericardial values, both at the septum (IBSsi) and the posterior
wall (IBSpwi). The measurements obtained for each cardiac cycle
were intensity of IBS at end-diastole (IBSed), intensity of IBS at
end-systole (IBSes), IBS variation (IBSVIBSedIBSes), and cyclic
variation index at the septum (CVIs) and posterior wall levels
(CVIpw), which were computed by use of the formula ([IBSedIBSes]/
IBSed) · 100.
Operating Myocardial Biopsy and Data Processing
During open heart surgery, biopsy samples weighting 30 to 80 mg were
removed from the LV septum, immediately frozen in liquid nitrogen,
and stored at 80°C. Tissues were fixed in 10% formalin and embed-
ded in paraffin. Sections (5 m) were stained with hematoxylin and
eosin and modified trichrome stain for histological evaluation. Digitized
pictures were visualized on a high-resolution color display (SAMPO,
Tao-Yuan-Hsien). The true color image analysis software package
KS300 version 1.2 (Kontron Elektronik GmbH) was run for interactive
manipulation, quantification of the images, and data collection. Geo-
metric calibration was set with erythrocyte diameter (7 m). The
different components of the myocardial biopsy were marked, calculated
by computer analysis, and expressed as micrometers squared. In
particular, the following parameters were analyzed: total area: the
overall area occupied by the myocyte and connective tissue; myocyte
area: the overall area occupied by the myocyte; connective area: the area
covered by fibrous connective tissue; and myocyte area/connective area:
the ratio between the area occupied by myocyte and the area covered by
connective tissue. All measurements were made without knowledge of
the clinical data.
Statistical Analysis
Continuous variables are expressed as mean1 SD. A multiple
group comparison was performed through an ANOVA, followed by
Scheffe’s test. Intragroup differences were evaluated by means of the
Student’s t test. The intraclass correlation coefficient (ri) was
calculated according to Bland and Altman’s procedure, with a 1-way
ANOVA used for repeated measurements.13 Relations between IBS
and 2D echocardiographic measurements were expressed in terms of
linear regression analysis. Receiver operating characteristic (ROC)
curve analysis was generated by a nonparametric method14 to test the
predictive discrimination of IBS parameters by the aortic and control
groups and between the aortic subgroups. A probability value of
0.05 was considered significant.
Results
Blood pressure and heart rate overlapped in patients with AS and
in the control group. Interventricular septum and posterior wall
thicknesses were greater in AS, and both left ventricular mass
index (by body surface, in g/m2) (LVMbs) and left ventricular
mass index (by height, in g/m2.7) (LVMh) were significantly
higher in the AS subgroups compared with control subjects
(Table 1). Left ventricular end-diastolic diameter was slightly
higher in the DSF subgroup compared with the NSF subgroup
and control subjects (Table 1). The E/A ratio was significantly
higher in control subjects (Table 1). Ejection fraction and
fractional shortening were significantly lower, by definition, in
the DSF subgroup (Table 1). The echo-derived hemodynamic
data regarding the aortic valve showed that both peak and mean
P were significantly higher in the DSF group, and the AVA
was significantly lower in the DSF group compared with the
asymptomatic AS subgroup. AVR and stroke work loss were
significantly higher in the group with DSF (Table 1). Regarding
IBS, in DSF the cyclic variation index and IBS variation, both at
the proximal level of the septum and of the posterior wall, were
significantly lower than in NSF and in control subjects (Table 2).
If we consider the IBSsi and IBSpwi, their values were signifi-
cantly higher in DSF than in NSF and in control subjects.
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For separating patients with AS with DSF and those with
NSF by using ROC curve analysis (Figure 1), (A) CVIs
yielded an area under curve of 0.930.04 (P0.001) (95%
CI, 0.86 and 0.99); (B) IBSsi showed the higher discrimi-
nating power, with an area under the curve of 0.970.00
(P1) (95% CI, 1.00 and 1.00), whereas (C) the variation
index at proximal septum level (IBSVs) showed an area
under the curve of 0.950.03 (P0.0001) (95% CI, 0.87
TABLE 1. Conventional Echo Doppler Parameters
Aortic Stenosis
DSF (A) (n16)
Aortic Stenosis
NSF (B) (n19) Control (C)
Parameters Mean SD Mean SD Mean SD
ANOVA
P
EDD, mm 54.2‡ 3.3 45.3† 4.6 50.2 4.1 0.05
FS, % 25.2‡ 4.4 40.5 6.3 35.1* 5.4 0.05
EF, % 41.4‡ 2.4 56.2 3.7 60.7* 4.3 0.05
DSth, mm 16.3 3.3 15.5† 3.7 9.7* 1 0.001
DPWth, mm 12.2 1.3 11.7† 1.8 9.6* 2.4 0.01
LVMbs, g/m2 186.8 44.5 158.7† 37.4 101.3* 12.4 0.001
LVMh, g/m2.7 85.4 23.6 78.4† 27 43.5* 5.5 0.001
mESS 77.8‡ 16.7 55.7 16.5 66.1 17.9 0.05
Peak E, m/s 0.85 0.1 0.76 0.1 0.72 0.1 NS
Peak A, m/sec 0.92 0.2 0.81† 0.2 0.47* 0.1 0.01
E/A ratio 0.96 0.2 0.99† 0.3 1.6* 0.3 0.03
IVRT, mms 78.6 7.9 81.6 5.9 85.8 8.3 NS
AS peak vel, m/s 4.7‡ 1.1 3.8† 1.3 1.3* 2.5 0.001
P Aortic peak, mm Hg 88.3‡ 14 78.5† 18 5.2* 3.1 0.001
P Aortic mean, mm Hg 67.9‡ 10.5 46.2† 10.2 4.3* 2.7 0.001
AVA, cm2 0.74‡ 0.13 0.97 0.16       0.05
AVR, dyn/s per cm5 349.8‡ 39 235.8† 59 22.4* 8.3 0.01
SWL, % 39.5 10.2 19.4 10.5 4.5 0.5 0.01
AVAc, cm2 0.67‡ 0.12 0.88 0.15         
Peak-to-peak gradient, mm Hg 78.5‡ 11.3 68.5 14.2         
EDD indicates end-diastolic diameter; FS, fractional shortening; DSth, diastolic interventricular
septum thickness; DPWth, diastolic posterior wall thickness; mESS, meridional end systolic stress;
IVRT, isovolumic relaxation time; and SWL, stroke work loss. Other abbreviations as defined in text.
*Comparison between C and A (P0.05).
†Comparison between C and B (P0.05).
‡Comparison between A and B (P0.05).
TABLE 2. Tissue Characterization Parameters
Controls (n25)
(C)
Aortic Stenosis
(n16)
Symptomatic (A)
Aortic Stenosis
(n19)
Asymptomatic (B)
Parame-
ters Mean SD Mean SD Mean SD
ANOVA
P
IBSSi, % 42.6 5.3 64.6‡ 5.7 52.4*† 6.2 0.01
IBSPWi, % 47.1 6.1 62.2‡ 5.3 55.3† 7.7 0.01
CVIS, % 30.4 5.0 12.7‡ 3.5 18.3*† 4.5 0.001
IBSVS, % 7.1 1.5 2.3‡ 1.5 4.5§* 1.3 0.001
CVIPW, % 41.2 6.6 13.2‡ 4.6 16.9† 5.3 0.001
IBSVPW (dB) 8.2 2.2 3.4‡ 1.8 5.4† 1.5 0.001
IBSSi indicates diastolic backscatter at proximal septum (by pericardium) (%); IBSPWi, diastolic
backscatter at proximal posterior wall (by pericardium) (%); CVIS, cyclic variation index at proximal
septum level (%); CVIPW, cyclic variation index at proximal posterior wall thickness (%); and IBSVPW,
variation index at proximal posterior wall thickness (dB).
*Comparison between A and B (P0.05).
†Comparison between C and B (P0.05).
‡Comparison between C and A (P0.05).
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and 0.99). By using an IBSsi 56.6% as a cutoff, patients
were discriminated as DSF and NSF, with a sensitivity of
100% and a specificity of 100% (Figure 1). For separating
patients with AS and control subjects through the use of ROC
curve analysis, (D) IBSVs pointed out an area under curve of
0.930.03 (P0.0001) (95% CI, 0.87 and 0.99); (E) IBSsi
yielded an area under curve of 0.710.06 (P0.001) (95%
CI, 0.58 and 0.84), whereas (F) CVIs showed the higher
discriminating power with an area under curve of 0.970.01
(P0.0001) (95% CI, 0.93 and 100). Using a CVIs 22.2%
as a cutoff, patients were identified with a sensitivity of 93%
and a specificity of 100% (Figure 1).
Histopathological Parameters Correlation With
IBS Variables
In each specimen, the main microscopic change was the
presence of abundant interstitial fibrosis. Connective tissue
surrounded isolated or small groups of myocytes. Myocytes
frequently showed size and shape variability and disarray of
myofibrils. No inflammatory infiltrate was found (Figure 2)
The histopathology data of the end-operative biopsy at the
septum level showed in particular the myocardial digitized
area (12.5 · 103 m2 3.5 · 103), compared with digitized
fibrotic area (47.3 · 103 m2 8.6 · 103), and the relative ratio
between myocytes and fibrotic area (0.260.06). We ob-
tained relevant and significant correlations between myocyte/
fibrosis ratio and IBS parameters: with IBSV septum
Figure 2. Histopathology of aortic stenosis (operating biopsy).
Figure 1. A, Receiving operating characteristic curve analysis for separating patients with AS with DSF and those with NSF (curves A
through C). B, Receiving operating characteristic curve analysis for separating patients with AS and control subjects (curves D through
F). For details, see text.
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(r0.70; P0.04), with CVI at septum level (r0.72;
P0.05), and with IBSsi, (r0.74; P0.02) (Figure 3).
Relation Between Quantitative Backscatter
Analysis Data, Echocardiographic, and
Hemodynamic Aortic Valve Parameters
Both cyclic variation index (CVI) and IBS variation at the
septum and posterior wall levels showed an inverse, signifi-
cant correlation with LVMbs (Table 3). Furthermore, both
CVI and IBSV at the septum and posterior wall levels showed
a significant inverse correlation with P both at peak and
mean (Table 3). A lesser degree of correlation was found
between IBSsi, IBSpwi, and structural and functional aortic
stenosis parameters. AVA and AVR showed a lesser degree
of correlation with backscatter parameters than the previous
described variables (Table 3).
Follow-Up Results
All patients with AVR had a good follow-up, with no
prosthetic dysfunction. If we considered the percentage of
variation of LVMbs after 1-year follow-up, we could point out
that in all patients, in a different amplitude, there was a
reduction of LVMbs; however, if we considered the EF
variation, we could note that 10 of 16 patients showed an
increased or constant EF. These patients were characterized
by a parallel decrease of IBSsi, whereas in the other 6 patients
the IBSsi value remained constant. Considering the IBSsi mean
before the AVR of the patients who showed EF improvement,
it was 56.22.6 and for other 6, it was 65.74.6 (P0.003).
It is relevant to note the concordance of this value with the
cutoff derived by ROC curve analysis for this variable in
discriminating patients with DSF by NSF. Another relevant
observation was the correlation between LVMbs, EF, and
IBSSi, in particular between LVMbs and IBSSi (r0.58;
P0.01), between EF and IBSSi (r0.76; P0.003),
and LVMbs and EF (r0.62; P0.01) (Table 4 and
Figure 4).
Discussion
Main findings of the study were (1) a significant inverse
correlation between backscatter parameters and aortic valvu-
lar pressure gradient (peak and mean); (2) a significant rela-
tion between IBI parameters and histopathology parameter
such as the myocardium/fibrosis ratio; (3) high discriminating
power between patients with AS and control subjects of CVI
at the septum level, whereas IBSsi was the best variable in
identifying patients with DSF and patients with NSF (ROC
curves); (4) 1 year after aortic valve replacement, we ob-
served a significant reduction of LV mass, and only if
pericardial indexed IBS value (reduction of interstitial fibro-
sis) decreased, it was possible to observe an improvement of
IBSV and EF; on the contrary, EF and IBSV remained
constant or slightly decreased.
These data confirmed the previous observations that IBS is
able to detect the increase of collagen tissue (fibrosis), which
occurs in aortic stenosis (inverse correlation between IBS
indexed by pericardium reflectivity and operating biopsy
myocardial/fibrosis ratio), and to point out precocious impair-
ment of LV myocardial intrinsic contractility (through CVI
and IBS variation). Furthermore, the pressure gradient across
the aortic valve is one of the independent factors that induces
intense fibrosis at the myocardial level in aortic stenosis.
A close correlation was described between cardiac function
and myocardial morphology in patients with AS; with worsening
of fibrosis and myocyte degeneration, LV end-diastolic pressure
increases, and later EF decreases.15 This should be taken into
account for any decision of surgical intervention. Myocyte
hypertrophy and reactive fibrosis are the first adaptive elements
to LV pressure-overload of AS; it follows myocyte degeneration
under complex humoral stimuli (ACE and TGF-1), which
interact with cellular genomic transcription capacity.16,17 Reduc-
tion of capillary density, myocardial cellular loss, and replace-
ment fibrosis complete this complex adaptive mechanism.
Our operating biopsy observations confirm that severe
aortic stenosis in old age is able to determine an abnormal
Figure 3. Plot of correlation between IBSsi and myocyte/fibrosis
ratio (operating biopsy).
TABLE 3. Correlation Matrix (Pearson’s Method)
LVMbs Ppeak Pmean AVA AVR
CVIs 0.63 (P0.005) 0.65 (P0.005) 0.77 (P0.001) 0.45 (P0.01) 0.43 (P0.04)
CVIpw 0.56 (P0.003) 0.84 (P0.001) 0.85 (P0.001) 0.40 (P0.05) 0.31 (NS)
IBSVs 0.54 (P0.001) 0.64 (P0.01) 0.73 (P0.001) 0.37 NS 0.22 (NS)
IBSVpw 0.48 (P0.004) 0.72 (P0.001) 0.76 (P0.001) 0.43 (P0.05) 0.34 (NS)
IBSsi 0.46 (P0.05) 0.50 (P0.01) 0.52 (P0.02) 0.31 (NS) 0.53 (P0.05)
IBSpwi 0.42 (P0.03) 0.55 (P0.01) 0.57 (P0.01) 0.30 (NS) 0.42 (P0.03)
Abbreviations as defined in text and Table 2.
Only aortic stenosis patients (n35). R and P values are shown for each correlation.
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increase of fibrotic tissue with a disproportionate ratio with
myocardial cellular components. These evident changes in
myocardial texture are reflected in an increase in absolute
myocardium reflectivity, as detected by IBS.
According to these observations, we can discriminate, with
a high level of power, aortic patients with DSF by AS with
NSF (ROC curves) essentially on the basis of IBS parame-
ters. The progressive increase of fibrosis, related to LV
pressure overload of aortic stenosis, induces an impairment of
myocardial function linked to an increase of myocardial
stiffness, which causes an increase of LV end-diastolic
pressure and a progressive reduction of contractility indexes.
One year after AVR, we observed in several patients a
collagen network resetting (as demonstrated by significant re-
duction of IBSsi and IBSpwi), LVMbs reduction, and EF improve-
ment (as confirmed by CVI and IBSV significant increase, for
both the septum and posterior wall).18,19
IBS could integrate conventional echo evaluation of LV
function in two ways: (1) the cross-point of increase in IBSsi over
which degenerative myocardial alterations in LV hypertrophy
could develop into CHF (see ROC), and (2) the initial functional
CVI and IBSV alterations, which reflect the intrinsic myocardial
contractility abnormalities. Both early impairment of IBS in-
dexes, together with clinical findings (increasing dyspnea, insert-
ing angina pectoris, or syncope) and Doppler evaluation of aortic
stenosis hemodynamics, allow identification of the patients with
CHF and aortic stenosis, separating them from those with
cardiomyopathy and AS. Therefore, IBS could identify those
patients most suitable for AVR before irreversible myocardial
damage is realized and with the best chance of postoperative
recovery and improvement.20
Study Limitations and Conclusions
One study limitation was the relatively low number of
patients, but on the contrary, the strength was strict inclusion
criteria. We did not enroll patients with EF35% because we
were interested in testing the early capability of IBS in
precociously detecting myocardial alterations before CHF
developed in patients with AS. Further investigation in a
greater AS study population, also with systolic dysfunction, is
needed to definitely confirm the diagnostic and prognostic
value of IBS parameters. Recent technological development
TABLE 4. Individual Change Percent Variation Before and After One Year of
Aortic Valve Replacement
Patients* LVMbs EF IBSSi IBSVs
1* 23, 6 36, 2 19, 6 48, 9
2* 14, 5 35, 0 18, 5 31, 3
3 19, 7 3, 1 6, 0 7, 7
4 8, 6 1, 5 5, 0 5, 2
5 11, 4 29, 9 1, 1 30, 8
6* 23, 2 35, 4 18, 2 51, 9
7 20, 9 23, 7 6, 8 3, 3
8 15, 1 12, 2 2, 1 49, 2
9 7, 4 13, 4 7, 7 54, 4
10* 35, 1 34, 3 20, 5 41, 5
11 11, 4 24, 3 5, 0 6, 2
12* 23, 2 36, 1 18, 2 38, 3
13 8, 6 20, 0 2, 5 26, 7
14* 15, 1 18, 1 10, 8 44, 4
15* 28, 3 39, 0 19, 4 37, 8
16 9, 1 19, 3 1, 4 38, 9
Mean before AVR LVMbs 183.848.5 EF 40.42.2 IBSsi 65.65.9 IBSVs 3.11.5
Mean after AVR 143.536.5 48.74.9 49.86.7 4.82.4
P (t paired) 0.05 0.05 0.01 0.05
Abbreviations as in text.
*Patients with improvement of LV function.
Figure 4. Individual plot of values of LV
mass; EF, and IBSsi before and after AVR
(1-year follow-up).
854 Circulation August 17, 2004
 by guest on May 4, 2012http://circ.ahajournals.org/Downloaded from 
of acoustic densitometry, consisting in high-frame IBS, might
greatly improve the analytic capability of the method.
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